These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
436 related articles for article (PubMed ID: 16889448)
1. Risk of diabetes mellitus associated with atypical antipsychotic use among patients with bipolar disorder: A retrospective, population-based, case-control study. Guo JJ; Keck PE; Corey-Lisle PK; Li H; Jiang D; Jang R; L'Italien GJ J Clin Psychiatry; 2006 Jul; 67(7):1055-61. PubMed ID: 16889448 [TBL] [Abstract][Full Text] [Related]
2. Risk of diabetes mellitus associated with atypical antipsychotic use among Medicaid patients with bipolar disorder: a nested case-control study. Guo JJ; Keck PE; Corey-Lisle PK; Li H; Jiang D; Jang R; L'Italien GJ Pharmacotherapy; 2007 Jan; 27(1):27-35. PubMed ID: 17192159 [TBL] [Abstract][Full Text] [Related]
3. Atypical antipsychotic drugs and diabetes mellitus in a large outpatient population: a retrospective cohort study. Østbye T; Curtis LH; Masselink LE; Hutchison S; Wright A; Dans PE; Schulman KA; Krishnan RR Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):407-15. PubMed ID: 15372671 [TBL] [Abstract][Full Text] [Related]
4. Retrospective cohort study of diabetes mellitus and antipsychotic treatment in a geriatric population in the United States. Feldman PD; Hay LK; Deberdt W; Kennedy JS; Hutchins DS; Hay DP; Hardy TA; Hoffmann VP; Hornbuckle K; Breier A J Am Med Dir Assoc; 2004; 5(1):38-46. PubMed ID: 14706127 [TBL] [Abstract][Full Text] [Related]
5. One-year risk of psychiatric hospitalization and associated treatment costs in bipolar disorder treated with atypical antipsychotics: a retrospective claims database analysis. Kim E; You M; Pikalov A; Van-Tran Q; Jing Y BMC Psychiatry; 2011 Jan; 11():6. PubMed ID: 21214937 [TBL] [Abstract][Full Text] [Related]
6. Antipsychotic exposure and type 2 diabetes among patients with schizophrenia: a matched case-control study of California Medicaid claims. Lambert BL; Chou CH; Chang KY; Tafesse E; Carson W Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):417-25. PubMed ID: 15786516 [TBL] [Abstract][Full Text] [Related]
7. Treatment adherence among patients with bipolar or manic disorder taking atypical and typical antipsychotics. Gianfrancesco FD; Rajagopalan K; Sajatovic M; Wang RH J Clin Psychiatry; 2006 Feb; 67(2):222-32. PubMed ID: 16566617 [TBL] [Abstract][Full Text] [Related]
8. Diagnoses associated with use of atypical antipsychotics in a commercial health plan: a claims database analysis. Citrome L; Kalsekar I; Guo Z; Laubmeier K; Hebden T Clin Ther; 2013 Dec; 35(12):1867-75. PubMed ID: 24119767 [TBL] [Abstract][Full Text] [Related]
9. Time to psychiatric hospitalization in patients with bipolar disorder treated with a mood stabilizer and adjunctive atypical antipsychotics: a retrospective claims database analysis. Kim E; Maclean R; Ammerman D; Jing Y; Pikalov A; You M; Van-Tran Q; L'Italien G Clin Ther; 2009 Apr; 31(4):836-48. PubMed ID: 19446157 [TBL] [Abstract][Full Text] [Related]
10. Rate of new-onset diabetes among patients treated with atypical or conventional antipsychotic medications for schizophrenia. Ollendorf DA; Joyce AT; Rucker M MedGenMed; 2004 Jan; 6(1):5. PubMed ID: 15208518 [TBL] [Abstract][Full Text] [Related]
11. Assessment of antipsychotic-related risk of diabetes mellitus in a Medicaid psychosis population: sensitivity to study design. Gianfrancesco F; Pesa J; Wang RH; Nasrallah H Am J Health Syst Pharm; 2006 Mar; 63(5):431-41. PubMed ID: 16484517 [TBL] [Abstract][Full Text] [Related]
12. Comparison of second-generation antipsychotic treatment on psychiatric hospitalization in Medicaid beneficiaries with bipolar disorder. Jing Y; Johnston SS; Fowler R; Bates JA; Forbes RA; Hebden T J Med Econ; 2011; 14(6):777-86. PubMed ID: 21954966 [TBL] [Abstract][Full Text] [Related]
13. New-onset treatment-dependent diabetes mellitus and hyperlipidemia associated with atypical antipsychotic use in older adults without schizophrenia or bipolar disorder. Erickson SC; Le L; Zakharyan A; Stockl KM; Harada AS; Borson S; Ramsey SD; Curtis B J Am Geriatr Soc; 2012 Mar; 60(3):474-9. PubMed ID: 22288652 [TBL] [Abstract][Full Text] [Related]
14. Patterns of discontinuation of atypical antipsychotics in the province of Québec: A retrospective prescription claims database analysis. Moisan J; Grégoire JP Clin Ther; 2010; 32 Suppl 1():S21-31. PubMed ID: 20152549 [TBL] [Abstract][Full Text] [Related]
15. Medication patterns and costs associated with olanzapine and other atypical antipsychotics in the treatment of bipolar disorder. Zhu B; Kulkarni PM; Stensland MD; Ascher-Svanum H Curr Med Res Opin; 2007 Nov; 23(11):2805-14. PubMed ID: 17910804 [TBL] [Abstract][Full Text] [Related]
16. Comparative study of the development of diabetes mellitus in patients taking risperidone and olanzapine. Fuller MA; Shermock KM; Secic M; Grogg AL Pharmacotherapy; 2003 Aug; 23(8):1037-43. PubMed ID: 12921249 [TBL] [Abstract][Full Text] [Related]
17. Antipsychotic drugs, mood stabilizers, and risk of pneumonia in bipolar disorder: a nationwide case-control study. Yang SY; Liao YT; Liu HC; Chen WJ; Chen CC; Kuo CJ J Clin Psychiatry; 2013 Jan; 74(1):e79-86. PubMed ID: 23419234 [TBL] [Abstract][Full Text] [Related]
18. Comparing adherence to and persistence with antipsychotic therapy among patients with bipolar disorder. Hassan M; Madhavan SS; Kalsekar ID; Makela EH; Rajagopalan K; Islam S; Kavookjian J; Miller LA Ann Pharmacother; 2007 Nov; 41(11):1812-8. PubMed ID: 17925501 [TBL] [Abstract][Full Text] [Related]
19. Hospitalization risk in bipolar disorder patients treated with lurasidone versus other atypical antipsychotics. Ng-Mak D; Halpern R; Rajagopalan K; Loebel A Curr Med Res Opin; 2019 Feb; 35(2):211-219. PubMed ID: 29625538 [TBL] [Abstract][Full Text] [Related]
20. A Retrospective Cohort Study of Acute Kidney Injury Risk Associated with Antipsychotics. Jiang Y; McCombs JS; Park SH CNS Drugs; 2017 Apr; 31(4):319-326. PubMed ID: 28290080 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]